Cuba to begin pediatric clinical trial with Soberana 02 and Soberana Plus
The Finlay Vaccine Institute (IFV) of Havana will initiate a clinical trial of the Soberana 02 and Soberana Plus vaccine candidates in the pediatric population. The trial will begin with a group of minors from 12 to 18 years old, and will later be extended to the group from 3 to 11 Read more